Brent L. Larson

This profile gathers the share dealings of Brent L. Larson in Navidea Biopharmaceuticals, Inc. The record holds 31 filings, for trades running from 12 May 2006 to 1 December 2015.

On the open market, the record shows 2 purchases worth €6,123 and 11 sales worth €266k. Netting one side against the other leaves €260k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 9 share grants and 8 option exercises. Since January 2015: no purchases and 9 sales on the market.

On 3 December 2015 came the latest disclosure, an open-market sale for €18k in Navidea Biopharmaceuticals, Inc. The clock since the last published purchase (8 November 2013) now reads 4,749 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.